Analytical Data
-
Gene name
FAM124B
- Application
-
Species
Human
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9H5Z6
-
Expression Region
1-455aa
-
Molecular Weight
56.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM124B (Family With Sequence Similarity 124 Member B) is a protein that has recently garnered attention in the field of molecular biology due to its potential role in various cellular processes and its implications in certain diseases. Research indicates that FAM124B may be involved in cellular signaling pathways, particularly in relation to cell proliferation and apoptosis. Its expression patterns suggest a significant role in developmental processes and possibly in tumorigenesis, making it a candidate for further investigation in cancer research. The recombinant form of FAM124B allows for the study of its biochemical properties, interactions with other proteins, and its functional effects in vitro and in vivo. Researchers are keen to explore the mechanisms by which FAM124B exerts its effects, as understanding these processes could reveal new therapeutic targets for cancers and other conditions where FAM124B dysregulation is implicated. Additionally, the production of recombinant FAM124B facilitates the development of assays for drug screening and the elucidation of its role in physiological and pathological states. Given the expanding knowledge of protein functions and their relevance to human health, FAM124B presents a promising area for further exploration in molecular and translational research.
